Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung
- 9 June 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 56 (9), 2291-2294
- https://doi.org/10.1038/s41409-021-01335-5
Abstract
No abstract availableKeywords
Funding Information
- MEXT | Japan Society for the Promotion of Science (18K12273)
- Morinaga Foundation For Health and Nutrition
This publication has 12 references indexed in Scilit:
- Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-DiseaseLung, 2017
- How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationBlood, 2017
- Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese PatientsJournal of Investigative Dermatology, 2016
- Clinical and immunological findings in 104 cases of paraneoplastic pemphigusBritish Journal of Dermatology, 2015
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2014
- Obliterative BronchiolitisThe New England Journal of Medicine, 2014
- Detection of autoantibodies to periplakin and envoplakin in paraneoplastic pemphigus but not idiopathic pulmonary fibrosis using full-length recombinant proteinsClinica Chimica Acta; International Journal of Clinical Chemistry, 2014
- Bronchiolitis Obliterans SyndromeSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2011
- Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantationEuropean Respiratory Journal, 2011
- Treatment of refractory chronic GVHD with rituximab: a GITMO studyBone Marrow Transplantation, 2007